EP3871661A4 - Composition injectable topique - Google Patents

Composition injectable topique Download PDF

Info

Publication number
EP3871661A4
EP3871661A4 EP20753264.9A EP20753264A EP3871661A4 EP 3871661 A4 EP3871661 A4 EP 3871661A4 EP 20753264 A EP20753264 A EP 20753264A EP 3871661 A4 EP3871661 A4 EP 3871661A4
Authority
EP
European Patent Office
Prior art keywords
injectable composition
topical
topical injectable
composition
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20753264.9A
Other languages
German (de)
English (en)
Other versions
EP3871661A1 (fr
Inventor
Jae Young Kim
Jeong Sun Nam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jetema Co Ltd
Original Assignee
Jetema Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jetema Co Ltd filed Critical Jetema Co Ltd
Publication of EP3871661A1 publication Critical patent/EP3871661A1/fr
Publication of EP3871661A4 publication Critical patent/EP3871661A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP20753264.9A 2019-02-08 2020-02-06 Composition injectable topique Withdrawn EP3871661A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190015232A KR102064864B1 (ko) 2019-02-08 2019-02-08 국소 주사용 조성물
PCT/KR2020/001686 WO2020162685A1 (fr) 2019-02-08 2020-02-06 Composition injectable topique

Publications (2)

Publication Number Publication Date
EP3871661A1 EP3871661A1 (fr) 2021-09-01
EP3871661A4 true EP3871661A4 (fr) 2022-07-13

Family

ID=69158535

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20753264.9A Withdrawn EP3871661A4 (fr) 2019-02-08 2020-02-06 Composition injectable topique

Country Status (8)

Country Link
US (1) US20210220260A1 (fr)
EP (1) EP3871661A4 (fr)
JP (1) JP7224687B2 (fr)
KR (1) KR102064864B1 (fr)
CN (1) CN112955125B (fr)
BR (1) BR112021008420A2 (fr)
CO (1) CO2021004004A2 (fr)
WO (1) WO2020162685A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102064864B1 (ko) * 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
WO2021172897A1 (fr) * 2020-02-26 2021-09-02 주식회사 엘지화학 Composition pharmaceutique comprenant l'acide désoxycholique
CN116617160A (zh) * 2023-07-25 2023-08-22 山东则正医药技术有限公司 水性混悬液及制备方法、冻干粉及应用、脂肪消减注射剂

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102591A1 (en) * 2010-01-26 2013-04-25 Andrew Lurie Salzman Compositions and methods for prevention and treatment of pulmonary hypertension
KR20130128658A (ko) * 2012-05-17 2013-11-27 (주)아모레퍼시픽 데옥시콜린산 또는 그의 염을 포함하는 조성물 및 효소의 안정화 방법
EP3299011A1 (fr) * 2016-09-22 2018-03-28 Kyoung Lack Lee Composition hypotonique décomposition de graisse et son procédé de préparation
KR101865562B1 (ko) * 2017-11-03 2018-06-08 주식회사 펜믹스 포스포콜린 유도체를 포함하는 지방분해 조성물
KR20190004087A (ko) * 2017-07-03 2019-01-11 진호성 지방제거용 주사제 조성물 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010045518A (ko) * 1999-11-05 2001-06-05 이규현 프로포폴의 안정화된 주사제용 약제학적 조성물 및 그의제조방법
MXPA06013437A (es) 2004-05-19 2007-03-23 Los Angeles Biomed Res Inst Uso de un detergente para la eliminacion no quirurgica de grasa.
AU2011375432B2 (en) 2011-08-23 2016-02-04 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
AU2015278833B2 (en) * 2014-06-27 2018-12-06 Medytox Inc. Methods and compositions of bile acids and salts for reduction of fat
JP2018532806A (ja) * 2015-11-04 2018-11-08 キセラ バイオファーマシューティカルズ インコーポレイテッド デオキシコール酸およびその塩による蓄積脂肪の処置方法
KR102064864B1 (ko) * 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102591A1 (en) * 2010-01-26 2013-04-25 Andrew Lurie Salzman Compositions and methods for prevention and treatment of pulmonary hypertension
KR20130128658A (ko) * 2012-05-17 2013-11-27 (주)아모레퍼시픽 데옥시콜린산 또는 그의 염을 포함하는 조성물 및 효소의 안정화 방법
EP3299011A1 (fr) * 2016-09-22 2018-03-28 Kyoung Lack Lee Composition hypotonique décomposition de graisse et son procédé de préparation
KR20190004087A (ko) * 2017-07-03 2019-01-11 진호성 지방제거용 주사제 조성물 및 이의 제조방법
KR101865562B1 (ko) * 2017-11-03 2018-06-08 주식회사 펜믹스 포스포콜린 유도체를 포함하는 지방분해 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020162685A1 *

Also Published As

Publication number Publication date
KR102064864B1 (ko) 2020-01-10
WO2020162685A1 (fr) 2020-08-13
JP2022506578A (ja) 2022-01-17
CO2021004004A2 (es) 2021-05-31
EP3871661A1 (fr) 2021-09-01
CN112955125B (zh) 2024-05-28
US20210220260A1 (en) 2021-07-22
CN112955125A (zh) 2021-06-11
BR112021008420A2 (pt) 2021-09-14
JP7224687B2 (ja) 2023-02-20

Similar Documents

Publication Publication Date Title
EP3659581A4 (fr) Composition topique
EP3888465A4 (fr) Composition antibactérienne
IL277213A (en) Topical preparation
EP3871661A4 (fr) Composition injectable topique
EP3985062A4 (fr) Composition
EP4077576A4 (fr) Composition d'agent d'étanchéité
EP3967296A4 (fr) Composition visqueuse
EP3681490A4 (fr) Compositions topiques
EP3898839A4 (fr) Composition d'asphalte modifiée
EP4077521A4 (fr) Composition d'agent d'étanchéité
EP3804720A4 (fr) Composition contenant du délamanid
EP3714702A4 (fr) Composition pour l'allergie de type i
EP4077522A4 (fr) Composition d'agent d'étanchéité
EP4005833A4 (fr) Composition de pneu
EP3991799A4 (fr) Composition visqueuse
EP3789035A4 (fr) Composition stabilisée
EP3679937A4 (fr) Composition dermatologique topique
AU2021902847A0 (en) Injectable composition
HK40072400A (en) Topical compositions
GB201918039D0 (en) Topical composition
AU2019900270A0 (en) Topical compositions
AU2018902736A0 (en) Topical composition
EP3981811A4 (fr) Composition
HK40073236A (en) New composition
AU2019902757A0 (en) Composition

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220614

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/16 20060101ALI20220609BHEP

Ipc: A61K 31/575 20060101ALI20220609BHEP

Ipc: A61P 3/04 20060101ALI20220609BHEP

Ipc: A61K 31/661 20060101ALI20220609BHEP

Ipc: A61K 47/26 20060101ALI20220609BHEP

Ipc: A61K 47/28 20060101ALI20220609BHEP

Ipc: A61K 9/19 20060101ALI20220609BHEP

Ipc: A61K 9/00 20060101AFI20220609BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230623

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20240625